Osteoporosis in females prior to menopause: Current concepts regarding definition, screening and management

Minerva Medica

Volumn 97, Issue 6, 2006, Pages 479-486

  Derk, C T ^a,b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Osteopenia bone mineral density; Osteoporosis, diagnosis; Osteoporosis, therapy; Premenopause

Indexed keywords

ALENDRONIC ACID; ANTICONVULSIVE AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CYCLOSPORIN A; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PARATHYROID HORMONE[1-34]; PREDNISONE; RALOXIFENE; RISEDRONIC ACID; SELECTIVE ESTROGEN RECEPTOR MODULATOR; VITAMIN D; BONE DENSITY CONSERVATION AGENT; GLUCOCORTICOID;

AMENORRHEA; ANOREXIA NERVOSA; BONE DENSITY; BULIMIA; CELIAC DISEASE; CLINICAL EVALUATION; CONNECTIVE TISSUE DISEASE; CORTICOSTEROID INDUCED OSTEOPOROSIS; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; EATING DISORDER; ENDOCRINE DISEASE; ENTERITIS; FEMALE; FRACTURE; GASTROINTESTINAL DISEASE; HEMOCHROMATOSIS; HUMAN; HYPERCORTISOLISM; HYPERPARATHYROIDISM; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOGONADISM; LOW DRUG DOSE; MALABSORPTION; MASS SCREENING; MENARCHE; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; OSTEOPOROSIS; OVARY INSUFFICIENCY; PREMENOPAUSE; REVIEW; RISK FACTOR; SYSTEMIC LUPUS ERYTHEMATOSUS; THALASSEMIA; WORLD HEALTH ORGANIZATION; STANDARD;

ANOREXIA NERVOSA; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BULIMIA; ENDOCRINE SYSTEM DISEASES; FEMALE; GASTROINTESTINAL DISEASES; GLUCOCORTICOIDS; HUMANS; MASS SCREENING; OSTEOPOROSIS; PREMENOPAUSE;

EID: 33847775047     PISSN: 00264806     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Saag KG, Morgan SL, Cao X. Bone in health and disease. In: Koopman WJ, Moreland LW editors. Arthritis and Allied conditions. Philadelphia: Lippincott Williams and Wilkins; 2005. p. 2473-41.
2. Lewiecki EM. Low bone mineral density in premenopausal women. S Med J 2004;97:544-50.
3. Bainbridge KE, Somers MF, Crutchfield M, Lin X, Jannausch M, Harlow SD. Natural history of bone loss over 6 years among premenopausal and early postmenopausal women. Am J Epidemiol 2002;156:410-7.
4. Slemenda C, Longscape C, Peacock M, Hui S, Johnston CC. Sex steroids, bone mass and bone loss: a prospective study of pre-, peri- and postmenopausal women. J Clin Invest 1996;97:14-21.
5. Matkovic V, Jellic T, Wardlaw G, Ilich JZ, Goel PK, Wright JK et al. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis: inference from a cross-sectional model. J Clin Invest 1994;93:799-808.
6. Bonnick S, Nichols D, Sanborn C, Lloyd K, Payne SG, Lewis L et al. Dissimilar spine and femoral Z-scores in premenopausal women. Calcif Tissue Int 1997;61:263-5.
7. Binkley N, Bilezikian JP, Kendler DL, Leib ES, Lewiecki EM, Petak SM. Official Positions of the International Society for Clinical Densitometry and Executive Summary of the 2005 Position Development Conference. J Clin Densit 2006;9:4-14.
8. Biller B, Saxe V, Herzog D, Rosenthal DI, Holzman S, Klibanski A. Mechanisms of osteoporosis in adult and adolescent women with anorexia nervosa. J Clin Endocrinol Metab 1989;68:548-54.
9. Grinspoon S, Thomas E, Pitts S, Gross E, Mickley D, Miller K et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med 2000;133:790-4.
10. Fogelholm GM, Sieramen HT, Kukkonen-Harjula TK, Pasanen ME. Bone mineral density during reduction, maintenance and regain of body weight in premenopausal obese women. Osteoporosis Int 2001;12:199-206.
11. Bacrach LK, Guido D, Katzman D, Litt IF, Marcus R. Decreased bone density in adolescent girls with anorexia nervosa. Pediatrics 1990;86:440-7.
12. Rigotti NA, Nussbaum SR, Herzog DB, Neer RM. Osteoporosis in women with anorexia nervosa. N Engl J Med 1984;311:1601-6.
13. Vestergaard P, Emborg C, Stoving RK, Hagen C, Mosekilde L, Brixen K. Fractures in patients with anorexia nervosa, bulimia nervosa, and other eating disorders- a nationwide register study. In J Eat Disord 2002;32:301-8.
14. Lucas AR, Melton LJ, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa. Mayo Clin Proc 1999;74:972-7.
15. Mehler PS. Osteoporosis in anorexia nervosa: prevention and treatment. Int J Eat Disord 2003;33:113-26.
16. American College of Rheumatology. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. 2001 update. Arthritis Rheum 2001;44:1496-503.
17. van Staa T, Lenfkens F, Cooper C. The epidemiology of corticosteroid-induced osteoporosis a meta-analysis. Osteoporosis Int 2002;13:777-87.
18. Israel E, Banerjee TR, Fitzmaurice GM, Kotlov TV, LaHive K, LeBoff MS. Effects of inhaled glucocorticoids on bone density in premenopausal women. N Engl J Med 2001;345:941-7.
19. Berenson AB, Radecki CM, Grady JJ, Rickert VI, Thomas A. A prospective controlled study of the effects of hormonal contraception on bone mineral density. Obstet Gynecol 2001;98:576-82.
20. Johansson B, Kaij L, Kullander S, Lenner HC, Svanberg L, Astedt B. On same late effects of bilateral oophorectomy in the age range 15-30 years. Acta Obstet Gynecol Scand 1975;54:449-61.
21. Miller KK, Klibanski A. Amenorrheic bone loss. J Clin Endocrin Metab 1999;84:1775-83.
22. Hermus A, Smals A, Swinkels L, Huysmans DA, Pieters GF, Sweep CF et al. Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrin Metab 1995;80:2859-65.
23. Ohmori N, Nomura K, Ohmori K, Kato Y, Itoh T, Takano K. Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J 2003;50:1-7.
24. Vestergaard P, Lindholm J, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P et al. Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocr 2002;146:51-6.
25. Klibanski A, Neer R, Beitins I, Ridgway EC, Zervas NT, McArthur JW. Decrease bone density in hyperprolactinimic women. N Engl J Med 1980;291:1511-4.
26. Cann C, Martin M, Genant H, Jaffe RB. Decreased spinal amenorrheic women. JAMA 1984;251:626-9.
27. Koppelman M, Kurtz D, Morrish K, Bou E, Susser JK, Shapiro JR. Vertebral body bone mineral content in hyperprolactinemic women. J Clin Endocrin Metab 1984;59:1050-3.
28. Vestergaard P, Jorgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L. Fracture risk is increased in patienst with GH deficiency or untreated prolactinomaa case-control study. Clin Endocrinol 2002;56:159-67.
29. Vestergaard P, Mosekilde L. Fractures in patients with hypethyroidism and hypothyroidism: a nationwide follow-up study in 16,149 patients. Thyroid 2002;12:411-9.
30. Pinchera A. Endocrinology and metabolism. London: McGraw-Hill; 2001.
31. Di Monaco M, Vallero F, Di Monaco R, Mautino F, Cavanna A. Primary hyperparathyroidism in elderly patients with hip fracture. J Bone Miner Metab 2004;22:491-5.
32. Fasano A, Berti I, Gerarduzzi T, Not T, Colletti RB, Drago S et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch Intern Med 2003;163:286-92.
33. Thomason K, West J, Logan KFA, Coupland C, Holmes GK. Fracture experience of patients with celiac disease: a population based survey. Out 2003;52:518-22.
34. th ed. Philadelphia: W.B. Saunders; 2001. p. 1635-52.
35. Michel BA, Bloch DA, Wolfe F, Fries JF. Fractures in rheumatoid arthritis: an evaluation of associated risk factors. J Rheumatol 1993;20:1666-9.
36. U.S. Preventive Services Task Force. Screening for osteoporosis in postmenopausal women: recommendations and rationale. Ann Intern Med 2002;137:526-8.
37. Neff MJ. Practice guidelines. ACOG releases guidelines for clinical management of osteoporosis. Am Fam Physician 2004;69:1558-60.
38. Atkinson SA, Abrams SA, Dawson-Hughes B et al. In: Young V editor. Dietary reference intake for calcium, phosphorus, magnesium, vitamin D and fluoride. Washington DC: National Academy Press. 1997. p. 91-143.
39. Pasco JA, Kotowicz MA, Henry MJ, Panahi S, Seeman E, Nicholson GC. Oral contraceptives and bone mineral density: a population-based study. Am J Obstet Gynecol 2000;182:265-9.
40. Prior JC, Kirkland SA, Joseph L, Kreiger N, Murray TM, Hanley DA et al. Oral-contraceptive use and bone mineral density in premenopausal women: cross-sectional population-based data from the Canadian Multicentre Osteoporosis Study. CMAJ 2001;165:1023-9.
41. Palomba S, Orio F Jr, Morelli M, Russo T, Pellicano M, Nappi C et al. Raloxifene administration in women treated with gonadotropin-releasing hormone agonist for uterine leiomyomas: effects on bone metabolism. J Clin Endocrinol Metab 2002;87:4476-81.